Extracorporeal Photochemotherapy in the Treatment of Severe Graft-Versus-Host Disease

References

• Clift R. A., Buckner C. D., Thomas E. D., Bensinger W. I., Bowden R., Bryant E., Deeg H. J., Doney K. C., Fisher L. D., Hansen J. A., Martin P., McDonald G. B., Sanders J. E., Schoch G., Singer J., Storb R., Sullivan K. M., Witherspoon R. P., Appelbaum F. R. Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclo-phosphamide. Blood 1994; 84: 2036
   PubMed Web of Science ®Google Scholar
• Greinix H. T., Reiter E., Keil F., Fischer G., Lechner K., Dieckmann K., Leitner G., Schulenburg A., Hoecker P., Haas O. A., Knoebl P., Mannhalter C., Fonatsch C., Hinterberger W., Kalhs P. Leukemia-free survival and mortality in patients with refractory or relapsed acute leukemia given marrow transplants from sibling and unrelated donors. Bone Marrow Transplantation 1998; 21: 673
   PubMed Web of Science ®Google Scholar
• Thomas E. D., Storb R., Clift R. A., Fefer A., Johnson F. L., Neiman P. E., Lerner K. G., Glucksberg H., Buckner C. D. Bone marrow transplantation. New England Journal of Medicine 1975; 292: 832
   PubMed Web of Science ®Google Scholar
• Hansen J. A., Gooley T. A., Martin P. J., Appelbaum F., Chauncey T. R., Clift R. A., Petersdorf E. W., Radich J., Sanders J. E., Storb R. F., Sullivan K. M., Anasetti C. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. New England Journal of Medicine 1998; 338: 962
   PubMed Web of Science ®Google Scholar
• Lee S. J., Kuntz K. M., Horowitz M. M., McGlave P. B., Goldman J. M., Sobocinski K. A., Hegland J., Kollman C., Parsons S. K., Weinstein M. C., Weeks J. C., Antin J. H. Unrelated donor bone marrow transplantation for chronic myeloid leukemia: a decision analysis. Annals of Internal Medicine 1997; 127: 1080
   PubMed Web of Science ®Google Scholar
• Ringden O., Deeg H. J. Clinical spectrum of graft-versus-host disease. In: Graft-vs-host disease, 2nd edn. M Dekker, New York 1997; 525
   Google Scholar
• Billingham R. E. The biology of graft-versus-host reaction. In:. The Harvey Lectures. Academic Press, New York 1966; 62: 21
   Google Scholar
• Korngold R., Sprent J. T cell subsets in graft versus host disease. In:. Graft-vs-host disease. M Dekker, New York 1990; 31
   Google Scholar
• Ferrara J. L. M., Deeg H. J. Graft-versus-host disease. New England Journal of Medicine 1991; 324: 667
   PubMed Web of Science ®Google Scholar
• Ferrara J. L. M. The cytokine modulation of acute graft-versus-host disease. Bone Marrow Transplantation 1998; 21(Suppl 3)13
   Google Scholar
• Antin J. H., Ferrara J. L.M. Cytokine dysregulation and acute graft-versus-host disease. Blood 1992; 80: 2964
   PubMed Web of Science ®Google Scholar
• Glucksberg H., Storb R., Fefer A., Buckner C. D., Neiman P. E., Clift R. A., Lerner K. G., Thomas E. D. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974; 18: 295
   PubMed Web of Science ®Google Scholar
• Rowlings P. A., Przepiorka D., Klein J. P., Gale R. P., Passweg J. R., Henslee-Downey P. J., Cahn J. Y., Calderwood S., Grat-wohl A., Socie G., Abecasis M. M., Sobocinski K. A., Zhang M. J., Horowitz M. M. IBMTR severity index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. British Journal of Haematology 1997; 97: 855
   PubMed Web of Science ®Google Scholar
• Atkinson K. Chronic graft-versus-host disease. Bone Marrow Transplantation 1990; 5: 69
   PubMed Web of Science ®Google Scholar
• Vallera D. A., Blazar B. R. T cell depletion for graft-versus-host disease prophylaxis. Transplantation 1989; 47: 751
   PubMed Web of Science ®Google Scholar
• Hale G., Waldmann H. Control of graft-versus-host disease and graft rejection by T cell depletion of donor and recipient with Campath-1 antibodies. Bone Marrow Transplantation 1994; 13: 597
   PubMed Web of Science ®Google Scholar
• Slavin S., Naparstek E., Nagler A., Ackerstein A., Samuel D., Kapelushnik J., Brautbar C., Or R. Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation. Blood 1996; 87: 2195
   PubMed Web of Science ®Google Scholar
• Storb R., Pepe M., Deeg H. J., Anasetti C., Appelbaum F. R., Bensinger W. I., Buckner C. D., Clift R. A., Doney K., Hansen J. A., Martin P. J., Pettinger M., Sanders J. E., Singer J., Stewart P., Sullivan K. M., Thomas E. D., Witherspoon R. P. Long-term follow-up of a controlled trial comparing a combination of metholrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia. Blood 1992; 80: 560
   PubMed Web of Science ®Google Scholar
• Storb R., Deeg H. J., Whitehead J., Appelbaum F., Beatty P., Bensinger W., Buckner C. D., Clift R., Doney K., Farewell V., Hansen J., Hill R., Lum L., Martin P., McGuffin R., Sanders J., Stewart P., Sullivan K., Witherspoon R., Yee G., Thomas E. D. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. New England Journal of Medicine 1986; 314: 729
   PubMed Web of Science ®Google Scholar
• Ratanatharathorn V., Nash R. A., Przepiorka D., Devine S. M., Klein J. L., Weisdorf D., Fay J. W., Nademanee A., Antin J. H., Christiansen N. P., Van der Jagt R., Herzig R. H., Litzow M. R., Wolff S. N., Longo W. L., Petersen F. B., Karanes C., Avalos B., Storb R., Buell D. N., Maher R. M., Fitzsimmons W E, Wingard J. R. Phase III study comparing methotrexate and tacrolimus (Prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation. Blood 1998; 92: 2303
   PubMed Web of Science ®Google Scholar
• Beatty P. G., Clift R. A., Mickelson E. M., Nisperos B. B., Flournoy N., Martin P. J., Sanders J. E., Stewart P., Buckner C. D., Storb R., Thomas E. D., Hansen J. A. Marrow transplantation from related donors other than HLA-identical siblings. New England Journal of Medicine 1985; 313: 765
   PubMed Web of Science ®Google Scholar
• Doney K. C., Weiden P. L., Storb R., Thomas E. D. Treatment of graft-versus-host disease in human allogeneic marrow graft recipients: A randomized trial comparing anti-thymocyte globulin and corticosteroids. American Journal of Hematology 1981; 11: 1
   PubMed Web of Science ®Google Scholar
• Martin P. J., Schoch G., Fisher L., Byers V., Anasetti C., Appelbaum F. R., Beatty P. G., Doney K., McDonald G. B., Sanders J. E., Sullivan K. M., Storb R., Thomas E. D., Witherspoon R. P., Lomen P., Hannigan J., Hansen J. A. A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment. Blood 1990; 76: 1464
   PubMed Web of Science ®Google Scholar
• Herve P., Tiberghien P., Racadot E., Plouvier E., Cahn J. Y. Prevention and treatment of acute GvHD - new modalities. Bone Marrow Transplantation 1993; 11(Suppl 1)103
   PubMedGoogle Scholar
• Sullivan K. M., Witherspoon R. P., Storb R., Deeg H. J., Dahl-berg S., Sanders J. E., Appelbaum F. R., Doney K. C., Weiden P., Anasetti C., Loughran T. P., Hill R., Shields A., Yee G., Shulman H., Nims J., Strom S., Thomas E. D. Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-versus-host disease. Blood 1988; 72: 555
   PubMed Web of Science ®Google Scholar
• Sullivan K. M., Witherspoon R. P., Storb R., Weiden P., Flournoy N., Dahlberg S., Deeg H. J., Sanders J. E., Doney K. C., Appelbaum F. R., McGuffin R., McDonald G. B., Meyers J., Schubert M. M., Gauvreau J., Shulman H. M., Sale G. E., Anasetti C., Loughran T. P., Strom S., Nims J., Thomas E. D. Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-versus-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation. Blood 1988; 72: 546
   PubMed Web of Science ®Google Scholar
• Volc-Platzer B., Hönigsmann H., Hinterberger W., Wolff K. Photochemotherapy improves chronic cutaneous graft-versus-host disease. Journal of the American Academy of Dermatology 1990; 23: 220
   PubMed Web of Science ®Google Scholar
• Edelson R., Berger C., Gasparro F., Jegasothy B., Heald P., Wintroub B., Vonderheid E., Knobler R., Wolff K., Plewig G., McKiernan G., Christiansen I., Oster M., Honigsmann H., Wilford H., Kokoschka E., Rehle T., Perez M., Stingl G., Laroche L. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. New England Journal of Medicine 1987; 316: 297
   PubMed Web of Science ®Google Scholar
• Knobler R. M., Graninger W., Graninger W., Lindmaier A., Trautinger F., Smolen J. S. Extracorporeal photochemotherapy for the treatment of systemic lupus erythema-tosus. Arthritis and Rheumatism 1992; 35: 319
   PubMed Web of Science ®Google Scholar
• Barr M. L., Meiser B. M., Eisen H. J., Roberts R. F., Livi U., Dall' Amico R., Dorent R., Rogers J. G., Radovancevic B., Taylor D. O., Jeevanandam V., Marboe C. C. Photo-pheresis for the prevention of rejection in cardiac transplantation. New England Journal of Medicine 1998; 339: 1744
   PubMed Web of Science ®Google Scholar
• Rook A. H., Freundlich B., Jegasothy B. V., Perez M. I., Barr W. G., Jimenez S. A., Rietschel R. L., Wintroub B., Kahaleh M. B., Varga J., Heald P. W., Stehen V., Massa M. C., Murphy G. F., Perniciaro C., Istfan M., Ballas S. K., Edelson R. L. Treatment of systemic sclerosis with extracorporeal photochemotherapy. Archives of Dermatology 1992; 128: 337
   PubMed Web of Science ®Google Scholar
• Gasparro F. P. The impact of psoralen photoadducts on cells. In:. Extracorporeal photochemotherapy. RG Landes Company, Austin 1994; 37
   Google Scholar
• Knobler R. M., Trautinger F., Graninger W., Macheiner W., Gruenwald C., Neumann R., Ramer W. Parenteral administration of 8-methoxy-psoralen in photopheresis. Journal of the American Academy of Dermatology 1993; 28: 580
   PubMed Web of Science ®Google Scholar
• Sniecinski I. Extracorporeal photochemotherapy: a scientific overview. Transfusion Sciences 1994; 15: 429
   PubMed Web of Science ®Google Scholar
• Besnier D. P., Chabannes D., Mahe B., Mussini J. M.G., Baranger T. A.R., Muller J. Y., Milpied N., Esnault V. L.M. Treatment of graft-versus-host disease by extracorporeal photochemotherapy. Transplantation 1997; 64: 49
   PubMed Web of Science ®Google Scholar
• Richter H. I., Stege H., Ruzicka T., Soehngen D., Heyll A., Krutmann J. Extracorporeal photopheresis in the treatment of acute graft-versus-host disease. Journal of the American Academy of Dermatology 1997; 36: 787
   PubMed Web of Science ®Google Scholar
• DaH'Amico R., Zacchello G. Treatment of graft-versus-host disease with photopheresis. Transplantation 1998; 65: 1283
   PubMed Web of Science ®Google Scholar
• Sniecinski I., Parker P., Dagis A., Collier T., Wang S., Rick-ard K., Snyder D., Nademanee A., Spielberger R., Rodriguez R., Krishnan A., Fung H., Stein A., O'Donnell M., Rosenthal J., Sahebi F., Kogut N., Falk P., Molina A., Loui W., Planas I., Niland J., Forman S. Extracorporeal photopheresis (EP) is effective treatment for chronic refractory graft-versus-host disease (GvHD). Blood 1998; 92(Suppl 1)454a
   Google Scholar
• Greinix H. T., Volc-Platzer B., Rabitsch W., Gmeinhart B., Guevara-Pineda C., Kalhs P., Krutmann J., Hönigsmann H., Ciovica M., Knobler R. M. Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease. Blood 1998; 92: 3098
   PubMed Web of Science ®Google Scholar
• Owsianowski M., Gollnick H., Siegert W., Schwerdtfeger R., Orfanos C. E. Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis. Bone Marrow Transplantation 1994; 14: 845
   PubMed Web of Science ®Google Scholar
• Rossetti F., Zulian F., Dall'Amico R., Messina C., Montini G., Zaccello E. Extracorporeal photochemotherapy as single therapy for extensive, cutaneous, chronic graft-ver-sus-host disease. Transplantation 1995; 59: 149
   PubMed Web of Science ®Google Scholar
• Balda B. R., Konstantinow A., Starz H., Gnekow A., Heide-mann P. Extracorporeal photochemotherapy as an effective treatment modality in chronic graft-versus-host disease. Journal of the European Academy of Dermatology and Venereology 1996; 7: 155
   Google Scholar
• Dall'Amico R., Rossetti R., Zulian F., Montini G., Murer L., Andreetta B., Messina C., Baraldi E., Montesco M. C., Dini G., Locatelli F., Argiolu F., Zaccello G. Photopheresis in paediatric patients with drug-resistant chronic graft-versus-host disease. British Journal of Haematology 1997; 97: 848
   PubMed Web of Science ®Google Scholar
• Abhyankar S., Bishop M. Adjunctive treatment of resistant chronic graft versus host disease with extracorporeal photopheresis using UVADEX sterile solution. Blood 1998; 92(Suppl 1)454a
   Google Scholar
• Bishop M. R., Ketcham M., Lynch J., Tarantolo S. R., Pav-letic Z. S., Oria N., Morris M., Reddy R. L., Armitage J. O., Kessinger A. Extracorporeal photopheresis permits steroid withdrawal in steroid-resistant chronic graft-versus-host disease. Blood 1998; 92(Suppl 1)455a
   Google Scholar
• Child F. J., Ratnavel R., Watkins P., Samson D., Apperley J., Ball J., Taylor P., Russell-Jones R. Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD). Bone Marrow Transplantation 1999; 23: 881
   PubMed Web of Science ®Google Scholar
• Wolfe J. T., Lessin S. R., Singh A. H., Rook A. H. Review of immunomodulation by photopheresis: treatment of cutaneous T-cell lymphoma, autoimmune disease, andal-lograft rejection. Artif Organs 1994; 18: 888
   PubMed Web of Science ®Google Scholar
• Lee K. H., Garro J, Jr. Engineering aspects of extracorporeal photochemotherapy. The Yale Journal of Biology and Medicine 1989; 62: 621
   PubMed Web of Science ®Google Scholar
• Vowels B. R., Cassin M., Boufal M. H., Walsh L. J., Rook A. H. Extracorporeal photochemotherapy induces the production of tumor necrosis factor-α by monocytes. Journal of Investigative Dermatology 1992; 98: 686
   PubMed Web of Science ®Google Scholar
• Yoo E. K., Rook A. H., Elenitsas R., Gasparro F. P., Vowels B. R. Apoptosis induction by ultraviolet light A and photochemotherapy in cutaneous T-cell lymphoma. Journal of Investigative Dermatology 1996; 107: 235
   PubMed Web of Science ®Google Scholar
• Aringer M., Graninger W. B., Smolen J. S., Kiener H. P., Steiner C. W., Trautinger F., Knobler R. Photopheresis treatment enhances CD95 (FAS) expression in circulating lymphocytes of patients with systemic sclerosis and induces apoptosis. British Journal of Rheumatology 1997; 36: 1276
   PubMedGoogle Scholar
• Enomoto D. N., Schellekens P. T., Yong S. L., Ten Berge I. J., Mekkes J. R., Bos J. D. Extracorporeal photochemotherapy (photopheresis) induces apoptosis in lymphocytes. Journal of Photochemistry and Photobiology 1997; 65: 177
   PubMed Web of Science ®Google Scholar
• Hanlon D. J., Berger C. L., Edelson R. L. Photoacti-vated 8-methoxypsoralen treatment causes a peptide-depen-dent increase in antigen display by transformed lymphocytes. International Journal of Cancer 1998; 78: 70
   PubMed Web of Science ®Google Scholar
• Van Lint M. T., Uderzo C., Locasciulli A., Majolino I., Scime R., Locatelli F., Giorgiani G., Arcese W., Lori A.P., Falda M., Bosi A., Miniero R., Alessandrino P., Dini G., Rotoli B., Bacigalupo A. Early treatment of acute graft-versus-host disease with high-or low-dose 6-methylpredniso-lone: a multicenter randomized trial from the Italian group for bone marrow transplantation. Blood 1998; 92: 2288
   PubMed Web of Science ®Google Scholar